(Q51517195)

6 April 2018

title

Ghrelin does not influence gastric emptying in obese subjects. (English)

1 reference

6 April 2018

0 references

6

Giovanni Gasbarrini

1 reference

6 April 2018

author name string

Maria E Valera Mora

1

1 reference

6 April 2018

Antonino Scarfone

2

1 reference

6 April 2018

Venanzio Valenza

3

1 reference

6 April 2018

Menotti Calvani

4

1 reference

6 April 2018

Aldo V Greco

5

1 reference

6 April 2018

Geltrude Mingrone

7

1 reference

6 April 2018

publication date

1 April 2005

1 reference

6 April 2018

published in

Obesity

1 reference

6 April 2018

volume

13

1 reference

6 April 2018

issue

4

1 reference

6 April 2018

page(s)

739-744

1 reference

6 April 2018

Endocrine and non-endocrine actions of ghrelin.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.83

Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.83

The hypothalamus and the control of energy homeostasis: different circuits, different purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.83

Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.83

Circulating ghrelin levels are decreased in human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.83

Delayed gastric emptying in the obese: an assessment using the non-invasive (13)C-octanoic acid breath test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.83

A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.83

Weight loss increases circulating levels of ghrelin in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.83

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.83

Peptidergic regulation of gastrointestinal motility in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.83

Centrally administered neuropeptide Y (NPY) inhibits gastric emptying and intestinal transit in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.83

Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.83

Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.83

Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.83

Gastric inhibitory polypeptide: the neglected incretin revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.83

Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.83

The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.83

21 January 2018

Identifiers

DOI

10.1038/OBY.2005.83

1 reference

6 April 2018

PubMed ID

15897483

1 reference

6 April 2018